Trial Profile
Analysis of gene polymorphism in hepatocellular carcinoma patients treated with sorafenib therapy
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 10 Feb 2015
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms AGHCs
- 10 Feb 2015 New trial record